@lynnaalnimerMD Profile picture

Lynna Alnimer, M.D.

@lynnaalnimerMD

Chief Gastroenterology Fellow @HenryFordProvidence 🇵🇸🇯🇴 #WomenInEndo #WomenInGI Interests: #GeneralGI #LiverDisease #CRC

Joined May 2011
Similar User
Laith Numan, MD, MS photo

@NumanLaith

Omar Tageldin (Tag), MD photo

@OmarMTag

Michelle Baliss, DO photo

@BalissMichelle

Katie Falloon photo

@KatieFalloonMD

Erik Holzwanger, MD, ABOM-D photo

@HilarHolzy

Bara Kurdi, MD photo

@BaraKurdiMD

Khaled Alsabbagh photo

@KAlsabb

Susan Lou photo

@SusanLouMD

Shifa Umar, MD photo

@shifaumarMD

Maham Hayat, MD photo

@MahamHayatMD

Muhammad Haseeb photo

@haseeb170

Asad ali photo

@Asadalidr

Ahmed Messallam photo

@MessallamMD

Muddasir Ayaz photo

@TheGastrologer

Thaer Abdelfattah MD,MPH photo

@tabdelfattahmd

Check out our latest review @LTxJournal 🎯Addressing metabolic issues in patients with MASH is of utmost importance, in both the pre and post LT setting; an individualized approach is necessary 🆕Resmetirom, endo-bariatrics and more have an increasing role in MASH

lynnaalnimerMD's tweet image. Check out our latest review @LTxJournal
🎯Addressing metabolic issues in patients with MASH is of utmost importance, in both the pre and post LT setting; an individualized approach is necessary
🆕Resmetirom, endo-bariatrics and more have an increasing role in MASH

Metabolic issues in patients with metabolic dysfunction-associated steatohepatitis (MASH) and their impact on MASH recurrence following Liver Transplantation: A narrative review by @NoureddinMD and colleagues journals.lww.com/lt/abstract/99…



Lynna Alnimer, M.D. Reposted

Glad to share our latest study on cirrhosis and chronic liver diseases in the MENA region—an important area given how understudied it is. Grateful to all my co-authors @WAleyadeh @AjlouniYazan @lynnaalnimerMD @Abdellatif_07 and for the mentorship of @basilenjei @AHNIMres

Key insights: •📈 Incidence of cirrhosis and chronic liver disease surged by 114.9% in the MENA region. •🌐 MASLD-related liver disease increased by 22.2%, highlighting a critical public health concern. •⬇️ Despite rising cases, mortality rates dropped by 54.3%, suggesting…

basilenjei's tweet image. Key insights:

•📈 Incidence of cirrhosis and chronic liver disease surged by 114.9% in the MENA region.
•🌐 MASLD-related liver disease increased by 22.2%, highlighting a critical public health concern.
•⬇️ Despite rising cases, mortality rates dropped by 54.3%, suggesting…


Lynna Alnimer, M.D. Reposted

In personal and professional life, steer away from pessimists, complainers and problem dwellers. Surround yourself with optimists, doers and problem solvers. Great energy only attracts great energy!


Last day for me at ⭐️ #ACG2024 Had a great time catching up with the @ScrubsNHeels family 🫶@GhadyMoafa @noorannemd @DCharabaty Participating in #EndoTitans💩 Hanging out with @MudePooja 🤍 Exploring new ☕️ 🥐places And of-course 🤓📚(PG course 🤩)

lynnaalnimerMD's tweet image. Last day for me at ⭐️ #ACG2024 
Had a great time catching up with the @ScrubsNHeels family 🫶@GhadyMoafa @noorannemd @DCharabaty 
Participating in #EndoTitans💩
Hanging out with @MudePooja 🤍
Exploring new ☕️ 🥐places
And of-course 🤓📚(PG course 🤩)

The highlight of #ACG2024 🌟 What a great gathering to catch up with old friends and meet new ones! 🤍 @GhadyMoafa @DCharabaty @maysaazoghbi @WAleyadeh @MKhadraMD @JosephHabibi_MD @SarahSafadiMD @MohamedEisaMD Looking forward to future events 💃🏼 #MENA

A huge THANK YOU to everyone who joined us at the first MENA reception! Your presence, enthusiasm, and support truly made the night. This is only the beginning, and we’re excited for what’s ahead! #MENA #MENAGI #ACG2024 #GITwitter

MENAGastro's tweet image. A huge THANK YOU to everyone who joined us at the first MENA reception! Your presence, enthusiasm, and support truly made the night. This is only the beginning, and we’re excited for what’s ahead! #MENA #MENAGI #ACG2024 #GITwitter


Lynna Alnimer, M.D. Reposted

✳️PCABs vs PPIs✳️ Mechanism of action differences PCABs➡️ Potassium competitive Acid Blockers PPIs➡️Proton Pump Inhibitors #MedTwitter #MedEd #GITwitter #MedGI Image courtesy: dovepress.com/article/fullte…

drdeepakmadhu's tweet image. ✳️PCABs vs PPIs✳️

Mechanism of action differences 

PCABs➡️ Potassium competitive Acid Blockers 

PPIs➡️Proton Pump Inhibitors 

#MedTwitter
#MedEd
#GITwitter
#MedGI

Image courtesy: dovepress.com/article/fullte…

Lynna Alnimer, M.D. Reposted

🚨📰🗞️Hot off the press— Our updated document on Quality indicators for Colonoscopy 👇🏼👇🏼👇🏼👇🏼 🎯All indication ADR >=35% 🎯ADR for abn stool test follow up >=50% 🎯SSLSR >=6% 🎯WT >=8 min And many more!!!

NEW! @AmCollegeGastro-@ASGEendoscopy Quality Indicators for Colonoscopy by Rex, et al. Guidelines published in @AmJGastro & @GIE_Journal emphasize the importance of determining & measuring priority quality indicators AJG ➡️ bit.ly/ACG-ASGE-Colon… GIE ➡️ bit.ly/ACG-ASGE-Colon…

AmJGastro's tweet image. NEW! @AmCollegeGastro-@ASGEendoscopy Quality Indicators for Colonoscopy by Rex, et al.

Guidelines published in @AmJGastro & @GIE_Journal emphasize the importance of determining & measuring priority quality indicators

AJG ➡️ bit.ly/ACG-ASGE-Colon…
GIE ➡️ bit.ly/ACG-ASGE-Colon…


Lynna Alnimer, M.D. Reposted

🔍 Cystic Neoplasms: ✅ Thick irregular rim ✅ Septations ✅ Solid parts ✅ Pancreatic duct >3mm, calcifications 💧 Low amylase in fluid 🔬Table: distinct traits 🚫 Sometimes, definitive diagnosis is tough 🌟 Serous cystic neoplasm: non-malignant, symptoms from size growth

EndoCollabcom's tweet image. 🔍 Cystic Neoplasms:

✅ Thick irregular rim
✅ Septations
✅ Solid parts
✅ Pancreatic duct >3mm, calcifications
💧 Low amylase in fluid
🔬Table: distinct traits
🚫 Sometimes, definitive diagnosis is tough
🌟 Serous cystic neoplasm: non-malignant, symptoms from size growth

Lynna Alnimer, M.D. Reposted

Endoscopic Diagnosis of Gastritis is Difficult A Thread 👇👇

EndoCollabcom's tweet image. Endoscopic Diagnosis of Gastritis is Difficult 

A Thread 👇👇

Proud of you - passionate, always working for a better future for his patients. Role model to all young professionals and the medical community. Way to go 🌟

It is with great pride we share that @yazansamhouri - our esteemed alum, was honored last night at the Pittsburgh’s 40 under 40, 2023 - for his groundbreaking research on TILs in solid organ malignancies. pittsburghmagazine.com/2023-40-under-…



Lynna Alnimer, M.D. Reposted

It is with great pride we share that @yazansamhouri - our esteemed alum, was honored last night at the Pittsburgh’s 40 under 40, 2023 - for his groundbreaking research on TILs in solid organ malignancies. pittsburghmagazine.com/2023-40-under-…


Lynna Alnimer, M.D. Reposted

"In clinical practice, NITs are being used more frequently to identify steatosis, fibrosis, and high-risk NASH instead of liver biopsy, which is invasive, expensive, and associated with risks." "The future of NASH diagnosis and management is heading towards non-invasive methods,…

FattyLiverA's tweet image. "In clinical practice, NITs are being used more frequently to identify steatosis, fibrosis, and high-risk NASH instead of liver biopsy, which is invasive, expensive, and associated with risks."

"The future of NASH diagnosis and management is heading towards non-invasive methods,…

Lynna Alnimer, M.D. Reposted

Rescue #TIPS must be considered as soon as posible in patients with cirrhosis and variceal bleeding who needs tamponade: 🥇 Rescue TIPS = 5-fold increase survival! #TLM22 #livertwitter

jturnesv's tweet image. Rescue #TIPS must be considered as soon as posible in patients with cirrhosis and variceal bleeding who needs tamponade:

🥇 Rescue TIPS = 5-fold increase survival!

#TLM22 #livertwitter
jturnesv's tweet image. Rescue #TIPS must be considered as soon as posible in patients with cirrhosis and variceal bleeding who needs tamponade:

🥇 Rescue TIPS = 5-fold increase survival!

#TLM22 #livertwitter

Catching up with friends from #MedSchool has been 🙌🏼🙌🏼 We haven’t aged 😌🇯🇴in #AASLD #TLM22

Best part about today was catching up with the HU squad @LynnaAlnimer and Sohail Haddadin! 🙌 #TLM22 #LiverMtg22 #AASLD @AASLDtweets

WAleyadeh's tweet image. Best part about today was catching up with the HU squad @LynnaAlnimer and Sohail Haddadin! 🙌 #TLM22 #LiverMtg22 #AASLD @AASLDtweets
WAleyadeh's tweet image. Best part about today was catching up with the HU squad @LynnaAlnimer and Sohail Haddadin! 🙌 #TLM22 #LiverMtg22 #AASLD @AASLDtweets


🌟high yield #DILI🌟by @RobertFontanaMD ✴️ idiosyncratic DILI; rare Dx ⏭️exclude others🦠🧪 ✴️use LiverTox; 🙌🏼 resource ✴️thorough H&P; ask about herbal supplements ✴️expert opinion, RUCAM ⏭️🆕RECAM ✴️DILI ➕ALF ⏩ LTx center #Hepatology #Liver #AASLD @AASLDtweets #TLM22

lynnaalnimerMD's tweet image. 🌟high yield #DILI🌟by @RobertFontanaMD 
✴️ idiosyncratic DILI; rare Dx ⏭️exclude others🦠🧪
✴️use LiverTox; 🙌🏼 resource
✴️thorough H&P; ask about herbal supplements
✴️expert opinion, RUCAM ⏭️🆕RECAM
✴️DILI ➕ALF ⏩ LTx center
#Hepatology #Liver #AASLD @AASLDtweets #TLM22
lynnaalnimerMD's tweet image. 🌟high yield #DILI🌟by @RobertFontanaMD 
✴️ idiosyncratic DILI; rare Dx ⏭️exclude others🦠🧪
✴️use LiverTox; 🙌🏼 resource
✴️thorough H&P; ask about herbal supplements
✴️expert opinion, RUCAM ⏭️🆕RECAM
✴️DILI ➕ALF ⏩ LTx center
#Hepatology #Liver #AASLD @AASLDtweets #TLM22
lynnaalnimerMD's tweet image. 🌟high yield #DILI🌟by @RobertFontanaMD 
✴️ idiosyncratic DILI; rare Dx ⏭️exclude others🦠🧪
✴️use LiverTox; 🙌🏼 resource
✴️thorough H&P; ask about herbal supplements
✴️expert opinion, RUCAM ⏭️🆕RECAM
✴️DILI ➕ALF ⏩ LTx center
#Hepatology #Liver #AASLD @AASLDtweets #TLM22
lynnaalnimerMD's tweet image. 🌟high yield #DILI🌟by @RobertFontanaMD 
✴️ idiosyncratic DILI; rare Dx ⏭️exclude others🦠🧪
✴️use LiverTox; 🙌🏼 resource
✴️thorough H&P; ask about herbal supplements
✴️expert opinion, RUCAM ⏭️🆕RECAM
✴️DILI ➕ALF ⏩ LTx center
#Hepatology #Liver #AASLD @AASLDtweets #TLM22

Lynna Alnimer, M.D. Reposted

Interesting study by Dr. Pan @nyulangone at #TLM22 @AASLDtweet In highly viremic CHB 🤰, TDF initiated at GA 14-16 wk ⬇️ MTCT to 0% when 👶 received HBV vaccines without HBIg similar safety data compared to 🤰 initiated TDF at GA 28 wk 🤔simplified approach? #LiverTwitter

HowardTLeeMD's tweet image. Interesting study by Dr. Pan @nyulangone at #TLM22 @AASLDtweet

In highly viremic CHB 🤰, TDF initiated at GA 14-16 wk ⬇️ MTCT to 0% when 👶 received HBV vaccines without HBIg

similar safety data compared to 🤰 initiated TDF at GA 28 wk

🤔simplified approach?
#LiverTwitter

Lynna Alnimer, M.D. Reposted

Important trial: stopping the transmission of HBV from mom to baby Starting HepB treatment at week 16 was safe and effective without the use of hep B immunoglobulin Calvin Pan’s work is changing the world #tlm22 #LiverTwitter

ebtapper's tweet image. Important trial: stopping the transmission of HBV from mom to baby

Starting HepB treatment at week 16 was safe and effective without the use of hep B immunoglobulin

Calvin Pan’s work is changing the world
#tlm22 #LiverTwitter
ebtapper's tweet image. Important trial: stopping the transmission of HBV from mom to baby

Starting HepB treatment at week 16 was safe and effective without the use of hep B immunoglobulin

Calvin Pan’s work is changing the world
#tlm22 #LiverTwitter

No HBIg available? Multi-center, RCT, 265 mothers, 269 infants 🎯Maternal TDF + infant vaccine = 💯success rate; 0 MTCT‼️ #HepB @AASLDtweets #TLM22 #PresidentialPlenary #hepatitisB #Hepatology

lynnaalnimerMD's tweet image. No HBIg available?
Multi-center, RCT, 265 mothers, 269 infants
🎯Maternal TDF + infant vaccine = 💯success rate; 0 MTCT‼️
 #HepB @AASLDtweets #TLM22 #PresidentialPlenary #hepatitisB #Hepatology

The best way to kick off my first #LiverMeeting: Great 🙌🏼review on #NASH. #Hepatology #Liver 🎯Prevalence of NAFLD in patients with #T2DM is 55.5% ‼️ Despite ✈️ delays and 🥱, so excited to be finally here #TLM22 #GI

lynnaalnimerMD's tweet image. The best way to kick off my first #LiverMeeting: Great 🙌🏼review on #NASH. #Hepatology #Liver 
🎯Prevalence of NAFLD in patients with #T2DM is 55.5% ‼️
Despite ✈️ delays and 🥱, so excited to be finally here #TLM22 #GI
lynnaalnimerMD's tweet image. The best way to kick off my first #LiverMeeting: Great 🙌🏼review on #NASH. #Hepatology #Liver 
🎯Prevalence of NAFLD in patients with #T2DM is 55.5% ‼️
Despite ✈️ delays and 🥱, so excited to be finally here #TLM22 #GI

Loading...

Something went wrong.


Something went wrong.